|
TYW1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.953600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.708400E-01 |
| Normal-vs-Stage2 |
1.980430E-01 |
| Normal-vs-Stage3 |
2.914800E-01 |
| Normal-vs-Stage4 |
4.067800E-01 |
| Stage1-vs-Stage2 |
1.474200E-01 |
| Stage1-vs-Stage3 |
1.823360E-01 |
| Stage1-vs-Stage4 |
3.028000E-01 |
| Stage2-vs-Stage3 |
2.603800E-02 |
| Stage2-vs-Stage4 |
5.660100E-02 |
| Stage3-vs-Stage4 |
7.935800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.625400E-01 |
| Normal-vs-AfricanAmerican |
7.578200E-02 |
| Normal-vs-Asian |
2.214300E-02 |
| Caucasian-vs-AfricanAmerican |
4.443700E-02 |
| Caucasian-vs-Asian |
7.642700E-03 |
| AfricanAmerican-vs-Asian |
2.603900E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.040600E-01 |
| Normal-vs-Female |
9.503400E-01 |
| Male-vs-Female |
7.742400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.841600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.182000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.800200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.245200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.499000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.452000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.399000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.929200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.312000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.956000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.517400E-03 |
| Classical-VS-Follicular |
5.334000E-01 |
| Classical-VS-Other |
5.605200E-01 |
| Classical-VS-Normal |
8.397200E-01 |
| Tall-VS-Follicular |
6.860900E-03 |
| Tall-VS-Other |
4.171600E-01 |
| Tall-VS-Normal |
2.432100E-02 |
| Follicular-VS-Other |
5.406600E-01 |
| Follicular-VS-Normal |
5.051800E-01 |
| Other-VS-Normal |
5.938800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.150400E-01 |
| Normal-vs-N1 |
9.278800E-03 |
| N0-vs-N1 |
4.142100E-03 |
|
|
